Evidence map›Paper›PMID 28003644›Full record

ArticleJournal of human genetics2017

Norrbottnian clinical variant of Gaucher disease in Southern Italy.

Simona Sestito, Mirella Filocamo, Ferdinando Ceravolo, Francesca Falvo, Michele Grisolia, Maria Teresa Moricca, Renato Cantaffa, Serena Grossi, Pietro Strisciuglio, Daniela Concolino

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Simona SestitoDepartment of Medical and Surgical Science, Paediatric Unit, University 'Magna Graecia', Catanzaro, Italy.
Mirella FilocamoCentro di diagnostica genetica e biochimica delle malattie metaboliche, Istituto G. Gaslini, Genoa, Italy.
Ferdinando CeravoloDepartment of Medical and Surgical Science, Paediatric Unit, University 'Magna Graecia', Catanzaro, Italy.
Francesca FalvoDepartment of Medical and Surgical Science, Paediatric Unit, University 'Magna Graecia', Catanzaro, Italy.
Michele GrisoliaDepartment of Medical and Surgical Science, Paediatric Unit, University 'Magna Graecia', Catanzaro, Italy.
Maria Teresa MoriccaDepartment of Medical and Surgical Science, Paediatric Unit, University 'Magna Graecia', Catanzaro, Italy.
Renato CantaffaHematology, 'Pugliese-Ciaccio' Hospital, Catanzaro, Italy.
Serena GrossiCentro di diagnostica genetica e biochimica delle malattie metaboliche, Istituto G. Gaslini, Genoa, Italy.
Pietro StrisciuglioDepartment of Translational Medical Science, Section of Paediatrics, University 'Federico II' of Naples, Naples, Italy.
Daniela ConcolinoDepartment of Medical and Surgical Science, Paediatric Unit, University 'Magna Graecia', Catanzaro, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Norrbottnian type of Gaucher disease (GD), as described many years ago, is due to a unique neuronopathic variant (c.1448T>G; L444P) that may have appeared during or before the sixteenth century in northern Sweden. It is a well-defined nosological entity with a characteristic course of clinical manifestations. In particular, Norrbottnian patients described in Sweden and Poland seem to share identical clinical histories characterized by the early onset of significant hepatosplenomegaly, often requiring splenectomy at an early age. Neurological involvement generally appears during the first or second decade of life, and includes horizontal gaze palsy, epilepsy, myoclonic movements, ataxia, dementia and cognitive impairment. Osteopenia occurs primarily in the spine, causing a severe and progressive thoracic kyphosis, although the involvement of other skeletal sites cannot be excluded. Here, we report on four Gaucher type 3 patients with Southern Italian ancestry presenting with clinical features and disease progression comparable to those of the 'Norrbottnian' Swedish phenotype, particularly regarding skeletal involvement with poor responsiveness to any therapeutical approach. Although a common ancestry among Southern Italian and Swedish Norrbottnian GD patients could not be investigated, the genotype [L444P]+[L444P] is the most frequently encountered in Southern Italy.

Indexed as

AdultAge of Onsetbeta-GlucosidaseFemaleGaucher DiseaseGenotypeHumansItalyMaleMiddle AgedPhenotypeSwedenbeta-Glucosidase

Identifiers

PMID28003644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.